chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pulse rate; Extreme thirsty; Fatigue; Low grade fever; Red knot at the site of injection; Red knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE (Pulse rate), THIRST (Extreme thirsty), FATIGUE (Fatigue), PYREXIA (Low grade fever) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced HEART RATE (Pulse rate), THIRST (Extreme thirsty), FATIGUE (Fatigue), PYREXIA (Low grade fever), VACCINATION SITE ERYTHEMA (Red knot at the site of injection) and VACCINATION SITE SWELLING (Red knot at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEART RATE (Pulse rate), THIRST (Extreme thirsty), FATIGUE (Fatigue), PYREXIA (Low grade fever), VACCINATION SITE ERYTHEMA (Red knot at the site of injection) and VACCINATION SITE SWELLING (Red knot at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-117917, MOD-2021-218767 (Patient Link).
Immediately -Dizziness, soon after-mouth itching, Hour later- severe nausea, abdominal pain ,rash,three hours later- facial swelling, tongue swelling,  epipen dose 1, trouble breathing on way to hospital and extreme dizziness. Epi dose 2. Arrive at hospital given IV and meds
Pt had first Shingrix vaccine on Tuesday 03/29/2022, that night she had fever and sore arm, Friday she developed full body hives and a swollen upper lip, feels itchiness in throat but no SOB or trouble swallowing, ears feel numb, itchy on scalp. No new meds, no new products, soaps, detergents, didn't eat anything unusual.
Sore Throat within first 36 hours progressed to fatigue and headache within 48 hours. Further progression led to nasal congestion and chest congestion. Within 4 days, fever and increased chest congestion with headache and general fatigue.
fever; dizziness; headache/head hurts feeling like it is going to split; aches all over; medicine taste in her mouth; This is a spontaneous report from a contactable consumer via the Medical Information Team. This consumer reported similar events for different patients. This is the second of two reports.  A female patient of unspecified age received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, unknown lot number and expiration date), via an unspecified route of administration on 12Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration date) on an unknown date. It was reported that the patient that she got her second vaccine and her friend got the vaccine same day and she is feeling the same way she is feeling: had fever, dizziness, headache (also reported as head hurts feeling like it is going to split), aches all over, medicine taste in her mouth, and has been in bed all day; all on unspecified dates. The outcome of the events was unknown.   Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021025705 same reporter/drug/event, different patients
Shortly after receiving the vaccine during the 15 minute observation period, patient reported feeling lightheaded and sweaty.  He appeared slightly pale.  Patient did not pass out.  911 was contacted and paramedics evaluated him.
Missed the last dose and took it late; A spontaneous report was received from the pharmacist on 21JUL2022. It described a patient of unknown age and gender who "missed the last dose and took it late" (PT: Inappropriate schedule of product administration). The patient took the Vivotif (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation. It was reported that the patient missed the last dose and took it late. Reportedly, the last dose was due on Friday (15JUL2022) and the patient did not take it until Tuesday (19JUL2022).  Action taken with Vivotif with respect to the reported event was not applicable.  The outcome of the reported event was unknown.  No additional information was reported.  Company comment: It was reported that a patient missed the last dose and took it late (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event.; Sender's Comments: It was reported that a patient missed the last dose and took it late (inappropriate schedule of product administration). Vivotif dose should be taken every other day, and the causality of inappropriate schedule of product administration is assessed as not applicable to Vivotif considering the nature of the event.
Military member received J&J vaccine on 27 March and then was positive for COVID on 22 April 2021.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2022 at 6:06 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 07-Feb-2022 at 6:06 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 07-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter. Treatment information was not provided. Patient took the booster dose on 07-Feb-2022 at 06:06:45 pm
Janssen COVID-19 Vaccine EUA  Extreme shivering started after 7 hrs of the vaccine, followed by temperature of 101+ , which remained for most of next 20 hrs, even after taking 3 Paracetamol 650 over that duration. Temperature reduced after fourth medicine, Tylenol 500, after approximately 30 hrs of vaccination, and has stayed at approx 98 degree since.
Hives on eyelids the evening of first hepatitis B vaccine. Mother related that she was achy all over and could not move the vaccinated arm. No treatment. Prophylactic Benedryl administered PO prior to second Hep B vaccine. No SE's reported.
Lightheaded, palpitations, very pale face and extremities, dizzy very tired, fatiguesd
Left supraclavicular lymphadenopathy, < 1 cm, but painful and persistent. Ongoing for 1 mo and still yet to improve.
Tested positive for coronavirus. Mild to moderate symptoms.  Day 1- chest tightness, sore throat, light cough Day 2- sore throat, slight congestion  Day 3- very congested, runny nose, neck pain Day 4- very congested, loss of taste and smell
Headache, Myalgia, Arthralgia & Fever  Narrative: missed work following second dose due to symptoms   Other Relevant History:
Dry mouth, swollen back of palate and extremely swollen uvula.   I woke up in the middle of the night with breathing trouble and slight gagging because of the size of my uvula.
Soreness at injection site; Tired; Dizzy; Chills; Headache; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date).   On 14th October 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 14th October 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, tiredness, dizziness, chills and headache. On 15th October 2019, the outcome of the injection site pain, tiredness, dizziness, chills and headache were recovered/resolved.   It was unknown if the reporter considered the injection site pain, tiredness, dizziness, chills and headache to be related to Shingrix.  Additional details were provided as follows: This case was reported by the wife of the patient. The reporter reported that she did not know when patient received his 1st dose. The patient received Shingrix and had injection site pain, tiredness, dizziness, chills and headache. The reporter consented to follow up. This case is 2 of 2 cases, reported by same reporter.
First night - fever, headache, pain, chills, sweats, etc.  Midnight of day 2, chest pain, shortness of breath, sweats.  Went to hospital at 8:15am.  Was diagnosed with pericarditis.
Nausea, lightheadedness, diaphoresis, bruising, and radiating pain from injection site.
Almost immediate exhaustion Severe stomach pain within 4 hours Vomiting within 5 hours Overnight fever and chills Chills, exhaustion, weakness, and dizziness for 24-36 hours
Diverticular hemorrhage. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Nurse reporting VAQTA was administered after expiration. No additional AE. No PQC.; Nurse reporting VAQTA was administered after expiration. No additional AE. No PQC.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided.   On 23-NOV-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (lot # U031911, expiration date: 11-NOV-2022, 0.5 ml, strength and route of administration were unknown) for prophylaxis after expiration (expired product administered). No additional adverse event (AE) was reported.
Pt who came in for a flu vaccine and was erroniously given a covid booster vaccination, We  kept Pt an extra 25-30 minutes on top of the 15 minutes required. She said she was feeling fine  before she left. 11/21/2021 @ 9:00pm I recieved a call from Pt's Uncle, stating that she had  difficulty breathing the night before and some chest pain as well. I told him to ask her how she was  feeling now. She said that she was having a hard time catching her breath and she was having some chest pain, I advised her and her Uncle to either call 911 or go to the ER 11/22/2021 @ 11:57am Spoke with Pt's uncle, he said they took Pt to ER, ER  ran some test on her and
fever; arm pain; feeling bad; This case was reported by a nurse and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose on unknown date, refer case US2020AMR246222).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, pain in arm and feeling bad. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever, pain in arm and feeling bad were unknown.   It was unknown if the reporter considered the fever, pain in arm and feeling bad to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced arm pain, fever and feeling bad for 3 days. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR246222:same reporter
Slight swelling in right mid thigh noted after exam in office at 2.00p on 6-9-04. Intractable crying start one hour after vaccines given. Tylenol to be given.
I received my 1st Covid shot on 12/21/20 and was diagnosed with Covid on 12/28/20. The day prior to testing positive I had been notified that I had been in close contact with someone who had tested positive. I did not have any symptoms when I tested positive on 12/28/20 except for a headache later that night. The next day I felt fatigued and had nasal congestion. On 12/30/20, i noticed that I had lost my sense of smell and my sense of taste was altered. I also felt mild chest tightness however my o2 sats remained above 95%. The congestion and fatigue only lasted for two days and my sense of smell and taste had come back by 1/1/21. The chest tightness has persisted even now after testing negative but has diminished over time and occurs less frequently.
W/in 24 hrs of RIG & 1st dose of vax c/o px swallowing & breathing, progressed to signif airway obstruct required intubation.  Rec'd rhesus monkey cell live vax for 2nd & 3rd dose. Similar rxn p/ 3 dose.  Did not complete series.
After the vaccine everything I ate or drank had a strong metallic taste, this lasted for 8 full days.
Discovered swollen lymph node underleft arm due to pain; Discovered swollen lymph node underleft arm due to pain; First 4 hours felt tingling throughout body.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included cervical fusion and associated pain. The patient was allergic to sulfa based. Concomitant medications included escitalopram oxalate (LEXAPRO) 5mg, fish oil (MANUFACTURER UNKNOWN), women's vitamin (MANUFACTURER UNKNOWN) and curcuma longa (TURMERIC); all for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 14:00 after 15 minutes of vaccination, the patient felt tingling throughout body for first 4 hours of vaccination. On 03Apr2021, the day 11 of vaccination the patient experienced swollen lymph node under left arm due to pain and was still present on day 17. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event of tingling throughout body was recovered on 23Mar2021; while that of the event of swollen lymph node under left arm due to pain was not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
left axillary LAD swelling   Narrative:  Left axillary LAD swelling occurring one day after 2nd dose of covid vaccine, leading to ED visit. No treatment given.
did not receive her second dose; This case was reported by a consumer via other manufacturer and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: the patient self reported the case. The age at vaccination was not applicable for this report. The reporter stated that, till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule, and had seen commercials, which mentioned getting a 2nd dose within 6 months of the first.
After I received my vaccine went to 30 min waiting area. I felt light headed they gave me juice and crackers. It is common procedure for nurse/paramedic to check your vitals. I was informed if I felt I needed to go to ER I refused. (Pt currently breast feeding the morning of the vaccine).
so sick; can't possibly drive herself to anywhere as she would be too afraid; can't possibly drive herself to anywhere as she would be too afraid; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 18Jan2021 a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced so sick and can't possibly drive herself to anywhere as she would be too afraid in on Jan2021. The clinical outcome of so sick and can't possibly drive herself to anywhere as she would be too afraid was unknown.  The batch/lot number for the vaccine, BNT162B2, was provided and has been requested during follow up.
2/26 - severe flu symptoms (achy, no energy), drastic increase in memory related issues (has mild cognitive impairment) 2/28 - vomiting and diarrhea
Within approx 11 hours of vaccine woke with severe chills, fever of 103°. This soon progressed to severe body aches, neck & shoulder pain, overall muscle weakness, loss of appetite, zaps of pain at left base of head. Overall felt like a severe flu. Half doses of Ibuprofen & Excedrin had little effect easing symptoms. but reduced fever to 100-101°. iSlept 10.5 hours and stayed in bed 24 hours - too weak to assume activities.  After 48 hours took half of Tylenol (250mg). Fever and body aches immediately responded. Had incident of vertigo. Have foggy brain, feeling dusconnected. Began to smell metal (phantom).  By 72 hours most symptoms resolve except for general weakness, joint pain, feeling disconnected and groggy, fatigued.
Initial report received on 16 September 2008 from a healthcare professional. A 2 month old male patient, whose medical history was unknown, received a first dose of PENTACEL (route, site and lot number unknown) on an unknown date. Within 30 minutes of administration, the patient developed a hypotonic hyporesponsive response. The patient was taken to the emergency room by ambulance. Corrective treatment was not reported. The patient's recovery status was reported as unknown.
pain, redness, swelling lt deltoid muscle inner axilla down to mid lt forearm;red streak w/o edema;T101-102;
- 5cm x 5.5cm erythematous area on L lateral deltoid, mild induration noted at superior aspect and slightly warm to touch. Pt denies pain but appears uncomfortable with palpation. No fluctuance. - 5cm x 4cm erythematous area on the L posterior upper arm. No warmth, induration or pain with palpation. Non-fluctuant -  low-grade fever of 101F x 24-36 hours after vaccines given.
10 days post vax the pt experienced a vesiculopapular rash on the trunk, arms, neck and scalp with 10 lesions and several reddened papules. The pt was treated with Zovirax.
Shortness of breath  Rapid heartbeat Elevated blood pressure Dizziness Felt faint
Patient reported and sent picture of a egg shaped red blotch on left arm at injection site.  Reports this developed 9 days after injection. She reported icing site. Redness and swelling did decrease after a few days.
pt recvd 2nd dose of vax 17SEP91 & 24SEP91 devel a rash, aching joints & a t101; 29SEP91 taken to ER dx measles; 4OCT91 devel conjunctivitis; h/a, fever, myalgia, arthralgia, fatigue, restricted ROM, muscle tenderness;
Soreness under the right arm, top of the right arm, and muscle pain in the neck and deltoid.
reddened, circular area around injection site approx 5inx5in chills, body aches, warm to touch
fever reached 103.5; COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 01Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Seasonal Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 18Apr2022, outcome "unknown" and all described as "COVID 19"; PYREXIA (non-serious) with onset 20Apr2022, outcome "recovered" (22Apr2022), described as "fever reached 103.5". The patient underwent the following laboratory tests and procedures: Pyrexia: 103.5, notes: my fever reached 103.5; SARS-CoV-2 test: Positive, notes: Now, 11 days after ending my course of treatment, 21 days after exposure and 17 days after symptom onset, I am still testing positive, albeit with a fading line and no symptoms; Symptomatic Covid. Therapeutic measures were taken as a result of covid-19, pyrexia.  Clinical course: On day 2 of symptomatic Covid, fever reached 103.5 and thus, patient began the 5-day course of Paxlovid that evening from 20Apr2022 to 25Apr2022 and ibuprofen from 19Apr2022 to 21Apr2022. Fever went away entirely in two days. According to tests, patient viral load already was fading during the course of treatment (a lightening line in RAT). However, three days (28Apr) after the course of treatment ended, that line rebounded. It became more pronounced in the week that followed.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient with history of COPD seen in ED on 6/13 with fever, cough, congestion, and myalgias. COVID-19 PCR test completed in the ED was positive, patient admitted from 6/13-6/16 with COVID-19 pneumonia. This meets criteria for vaccine breakthrough case review.
Redness, itching, and rash started on upper left arm, shoulder and onto chest and back - approx 8 inches on 9/20/16 at 3:00pm. Lasted until 9/22/16 AM. Almost completely gone at 9/22/16 - 8:45AM.
After 4 hours from when the shot was administered, I had an extreme itch starting with my head, wrists, and armpits. I began to see rashes and welting. I took Benadryl which calmed it down for an hour. However, that night my vision became very blurry and I was extremely dizzy. The following day, I woke up with hives all over my legs, arms, chest, and back. I took more Benadryl, however these rashes and hives remained a problem all day long. That night, my lips trippled in size and were very swollen. My hands and feet began to burn and rash. I contacted a doctor and was told to to go to the ER if my breathing was compromised. My throat was a little swollen, however it went down and was not as swollen as my lips. By the fourth day, I was feeling better with little to no rashing.